NBN Classic: Matt Oram, "The Trials of Psychedelic Therapy: LSD Psychotherapy in America" (Johns Hopkins UP, 2018)

episode

New Books in Drugs, Addiction and Recovery not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from New Books in Drugs, Addiction and Recovery

Ben Westhoff ed.,"Lives Interrupted: The Fentanyl Tragedy" (Arsenault Family Foundation, 2026) 27 min · 09 Sep 2026

All episodes from New Books in Drugs, Addiction and Recovery →

Report any issue

Source

Recorded02 Oct 2022

Publisherfeeds.megaphone.fm

Handlerec:5381057

Show notes

This episode proved remarkably popular, so we're reposting it as an NBN classic for those who missed it the first time. Are we in the midst of a psychedelic renaissance? If so, what can we learn about the present moment through the history of psychedelic experiments in the past? Matt Oram discusses contemporary debates about LSD and MDMA and brings much-needed context with his new book, The Trials of Psychedelic Therapy: LSD Psychotherapy in America (Johns Hopkins University Press, 2018), Oram talks about the role of psychiatry and the pharmaceutical industry as well the field of drug regulation. He underlines, too, that the history of psychedelics is a lot more complicated than researchers have previously suggested. Lucas Richert is an associate professor in the School of Pharmacy at the University of Wisconsin, Madison. He studies intoxicating substances and the pharmaceutical industry. He also examines the history of mental health. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.